News

Understanding Biotalys' Voting Rights and Share Capital Structure

Understanding Biotalys' Voting Rights and Share Capital Structure

Understanding Biotalys' Share Capital and Voting Rights

Biotalys NV, an Agricultural Technology company headquartered in Ghent, is actively developing innovative protein-based biocontrol solutions aimed at revolutionizing crop protection. The company emphasizes creating sustainable alternatives to conventional chemical pesticides, ensuring a safer food supply for all. Today, we're delving into the intricacies of Biotalys’ share capital and the crucial voting rights associated with its securities.

Overview of Biotalys' Share Capital

The outstanding share capital of Biotalys is valued at approximately EUR 5,540,603.84. This figure represents a vital aspect of the company's financial health and investor confidence. Biotalys’ total number of securities that carry voting rights stands at 37,470,062, consisting entirely of ordinary shares. This number signifies the equity available to current and potential stakeholders, enhancing the democratic nature of corporate governance within the company.

Total Voting Rights Explained

Every single share represents a voting right, making the total number of voting rights equal to the total number of ordinary shares, which again is 37,470,062. Understanding this figure is essential for shareholders as it directly influences their ability to affect company decisions through voting at annual general meetings and other crucial gatherings.

Additional Securities and Rights

In addition to standard shares, Biotalys has issued rights to subscribe for additional voting securities. Currently, there are:

  • 1,964,400 ESOP Warrants, which give holders the right to subscribe for new shares that could potentially convert into 982,200 securities carrying voting rights.
  • 1,130,397 additional ESOP Warrants available for subscription, enhancing the overall shareholding dynamics.
  • 23,926 share units awarded to independent directors, each entitling the holder to subscribe to new ordinary shares at an attractive issue price, fostering a culture of ownership within the company’s leadership.

These securities underline Biotalys' commitment to attract and retain talent while aligning the interests of its directors and shareholders.

Compliance and Disclosure Obligations

In compliance with the Belgian Act of 2 May 2007, Biotalys requires all stakeholders to notify the company and the relevant regulatory body when their voting rights cross critical thresholds. These thresholds are set at 5% and every subsequent five percentage points of the total voting rights. This process ensures transparency and maintains an open communication channel between the company and its investors.

Importance of Transparency for Investors

This disclosure requirement is crucial as it helps maintain an authentic and trustworthy relationship between Biotalys and its stakeholders. By keeping shareholders informed about any significant changes in voting rights, the company empowers its investors to make informed decisions regarding their investments.

Biotalys’ Commitment to Sustainable Agriculture

Founded in 2013, Biotalys has positioned itself as a pioneer in the AgTech sector, continuously working towards developing safer, environmentally friendly methods for pest control. This innovative use of their AGROBODY™ technology aims not only to combat key crop pests but also to ensure a robust safety profile in their product candidates.

Support for Sustainable Food Supply Chains

By aligning its business strategy with the demand for sustainable agriculture, Biotalys plays a vital role in fostering healthier food supply chains from soil to plate. As the company leverages its scientific advancements, shareholders can expect continued innovation and growth, reinforcing their investment in Biotalys NV.

Contact Information for Further Inquiries

If you have any questions or require additional information about Biotalys, please feel free to reach out to:

Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com

Frequently Asked Questions

What is Biotalys NV?

Biotalys NV is an Agricultural Technology company focused on developing biocontrol solutions for sustainable crop protection.

What is the value of Biotalys' share capital?

The total share capital of Biotalys is approximately EUR 5,540,603.84.

How many voting rights does Biotalys have?

Biotalys has a total of 37,470,062 voting rights associated with its ordinary shares.

What are ESOP Warrants?

ESOP Warrants are rights that allow holders to subscribe for new shares, potentially converting them into voting securities.

How does Biotalys ensure transparency with its shareholders?

Biotalys mandates notifications from shareholders when their voting rights exceed specific thresholds to maintain transparency and open communication.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Systemair Shakes Things Up: Closing Netherlands Facility

Updated Category News Views 81

Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 23

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector

Updated Category News Views 35

Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...

Continue Reading
Cork's Market Power Surges in U.S. Wine Industry

Updated Category News Views 0

Cork: The Unsung Hero of the Wine Bottle You'd think a simple piece of bark couldn't shift the billion-dollar wine industry, but cork closures are doing just that. According to new NielsenIQ data, these natural stoppers are holding their ground as top dogs in the U.S. wine market. Who would've guessed that cork would drive the highest off-premise revenue? That's some...

Continue Reading
Human Judgment Crucial Amid AI Growth in Courts

Updated Category News Views 67

AI in the Justice System: Balancing Potential and Pitfalls You know, when it comes to upholding justice, there's a line between what machines can handle and what only a human can bring to the gavel. Chief Justice Sundaresh Menon of Singapore threw the spotlight on this at an event in Brisbane, hammering home the need for good ole human intuition in the courtroom even as...

Continue Reading
Benewake Unveils SR Series LiDAR for Mobile Robots

Updated Category News Views 34

Wave Goodbye to Bulky Sensors Hot off the Beijing press, Benewake's got something new—the SR Series 360° 3D LiDARs, set to stir up the robotics world. They're compact, power-efficient, and packed with smarts. It seems Benewake is tapping into a juicy market with these little sensors. Sleek Design and Big Promises The SR18 and SR96 models have a lot going for them. The...

Continue Reading
Furniture Quality: Expert Tips for Savvy Shoppers

Updated Category News Views 0

Picking Apart Furniture Quality Before a Purchase In a world where cheap and flashy often overshadow durability, knowing what makes furniture stand the test of time isn't just wise—it's essential. Learn from Nate Bartlett, the furniture sage from Charlevoix, Michigan, who guides shoppers through the maze of quality indicators in a recent HelloNation article. If you're...

Continue Reading
Webull Faces Class Action: Investor Impact Deep Dive

Updated Category News Views 129

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 53

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Phrontline's TJ101 Gains Momentum in Cancer Clinical Trials

Updated Category News Views 75

Encouraging Signs from Phrontline's TJ101 ADC Trials In the high-stakes race to outsmart cancer, Phrontline Biopharma is banking on TJ101, their star investigational bispecific antibody-drug conjugate (ADC). The recent results shared at the ESMO Congress 2026 are stirring up quite a bit of chatter. Urothelial Carcinoma and Beyond Now, picture this: six of eight evaluable...

Continue Reading

Top 5 Most Recently Viewed Articles

BridgeBio Pharma Set to Showcase Innovations at Conference

Updated Category News Views 166

BridgeBio Pharma Announces Participation in Key Healthcare Conference BridgeBio Pharma, Inc. (NASDAQ: BBIO), a pioneering biopharmaceutical company committed to genetic disease research, has announced its participation in a major healthcare conference. During this significant event, co-founder and CEO, Neil Kumar, Ph.D., will take center stage to share insights into the...

Continue Reading
Experience the Artistry of the Sistine Chapel in Austin

Updated Category News Views 197

The Unveiling of the Sistine Chapel Experience in Austin Prepare to embark on an extraordinary journey through art and culture with the grand reveal of The Sistine Chapel Experience. This captivating digital reconstruction of Michelangelo's monumental frescoes brings the exquisite details of this historical masterpiece to life like never before. Located at the Barton...

Continue Reading
Aurora Spine Launches Innovative AERO™ Lumbar Fusion System

Updated Category News Views 148

Aurora Spine Introduces the AERO™ Lumbar Fusion System Aurora Spine Corporation has taken a significant step forward in the realm of spinal health solutions with the announcement of surgeries using its newly launched AERO™ Lumbar Fusion System. The initial surgeries were conducted by both an orthopedic surgeon and an interventionalist, marking a crucial milestone in...

Continue Reading
Pyxis Oncology Advances PYX-201 Trials for Cancer Treatment

Updated Category News Views 166

Exciting Developments at Pyxis Oncology In the realm of oncology, advancements in treatment options can spark hope for many patients facing difficult diagnoses. Pyxis Oncology, Inc., a company at the forefront of next-generation cancer therapies, has recently announced exciting progress in their clinical trials featuring PYX-201. This innovative drug represents potential...

Continue Reading
Skanska Secures Major Surgery Center Contract with Sutter Health

Updated Category News Views 371

Skanska's New Contract with Sutter Health Skanska has successfully signed a significant contract with Sutter Health to develop an ambulatory surgery center and a specialty clinic. This project holds a contract value of USD 55 million, approximately SEK 600 million, and it will positively impact the order bookings in the US for early 2025. Project Overview and Features The...

Continue Reading